Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

BUY
$57.77 - $65.93 $982 - $1,120
17 New
17 $0
Q1 2022

May 05, 2022

BUY
$66.02 - $79.71 $396 - $478
6 New
6 $0
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $380 - $444
-6 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $412 - $504
6 New
6 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.